Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wellgistics Health (WGRX) EBIT (2024 - 2025)

Wellgistics Health filings provide 2 years of EBIT readings, the most recent being $47.1 million for Q4 2025.

  • On a quarterly basis, EBIT rose 4821.11% to $47.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$21.3 million, a 1376.8% decrease, with the full-year FY2025 number at -$21.3 million, down 1376.8% from a year prior.
  • EBIT hit $47.1 million in Q4 2025 for Wellgistics Health, up from -$31.5 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $47.1 million in Q4 2025 to a low of -$31.5 million in Q3 2025.